evitria is an established, global antibody expression service provider specializing in CHO-based transient expression of antibodies (including bispecific and fusion antibodies).
With a track record of more than 60,000 transfections performed and more than 10,000 antibodies/antibody-based molecules expressed and purified for our clients from the Americas, Europe, Asia and Australia – ranging from academic laboratories and small biotech start-ups to global biopharmaceutical companies – you can benefit from our expertise when looking to entrust a partner with your complete antibody production or to manage capacity bottlenecks with single projects.